Lytix Biopharma
Records under this name other than patents Lytix Biopharma holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Lytix Biopharma
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,439,228 | Bioactive Peptides Lapsed on the fee record Ended Oct 21, 2020 · High confidence | Lapsed on the fee record | Ended Oct 21, 2020 | High confidence |
| US 7,232,803 | Antimicrobial compounds and formulations Formerly held Lapsed on the fee record Ended Jun 19, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 19, 2019 | USPTO record |
| US 6,890,902 | Cytotoxic Modified Lactoferrin Peptides Lapsed on the fee record Ended May 10, 2017 · High confidence | Lapsed on the fee record | Ended May 10, 2017 | High confidence |
| US 7,393,824 | Methods of peptide preparation Lapsed on the fee record Ended Jul 1, 2016 · USPTO record | Lapsed on the fee record | Ended Jul 1, 2016 | USPTO record |